Market & Regulation
HUD's AI Use in Policy Decisions Lacks Transparency
WIRED AIhigh confidence
Why it matters
- →Lack of transparency in AI use raises concerns about biases in policymaking.
- →Current laws do not require disclosure of AI's role in government decisions.
- →Understanding AI's impact on policy is crucial for public trust and accountability.
The Department of Housing and Urban Development (HUD) is facing criticism for its opaque use of AI in policy decisions, as it has denied Freedom of Information Act requests for documents detailing this use. The withheld documents suggest AI tools were employed to identify regulations for potential rescission, but the exact nature of their use remains undisclosed. This lack of transparency raises concerns about the potential biases and inaccuracies AI might introduce into government policymaking. The situation underscores the need for clear guidelines on AI's role in government decisions, as there are currently no laws requiring disclosure of AI use in policy creation.
Read originalMore from WIRED AI
© WIRED AIGeneral AIwriting
Apple's Siri AI Revamp Debuts in iOS 27 Beta
Apple's latest iOS 27 beta introduces a significant overhaul of Siri, transforming it into a more integrated and versatile tool across the iPhone ecosystem. The new Siri AI offers a chatbot-style app and enhanced functionality, allowing users to perform tasks like finding photos or sending texts with ease. This update marks a shift in how users can interact with their devices, making Siri a more central part of the iPhone experience. While not flawless, the revamped Siri AI is a promising step forward, potentially changing how iPhone owners engage with their smartphones.
WIRED AI
© WIRED AIResearchresearch
Quantum Computing Boosts AI in Drug Discovery
In a groundbreaking experiment, researchers at the Technical University of Denmark have demonstrated that quantum computing can enhance AI models for drug discovery. By integrating a quantum computer from ORCA Computing with traditional processors, they generated novel peptides, crucial for vaccine development, more effectively than classical methods. This hybrid approach shows promise in accelerating personalized immunotherapies and improving drug efficacy, especially in understudied populations. While quantum computing is still in its infancy, this study provides a tangible example of its potential in real-world applications.
WIRED AI
More in Market & Regulation
© SiftedInvestment · $700M
Market & Regulationbusiness
Neko Health raises $700M Series C funding
Neko Health has successfully raised $700 million in Series C funding, marking a pivotal moment for the company. With 100,000 members and profitability at the clinic level, this funding round is a testament to the company's robust growth and operational success. The investment is set to drive further expansion and innovation in their healthcare services, potentially reshaping the landscape of healthcare delivery. Neko Health's strategic position in the health tech industry is strengthened by this substantial financial backing, which reflects strong investor belief in its business model and future trajectory.
Sifted
© SiftedInvestment · $15M
Market & Regulationbusiness
Meticulous raises $15M to enhance AI code testing
Meticulous, a London-based startup, has secured $15 million in Series A funding to advance its AI-driven code testing platform. Founded by ex-Palantir and Dropbox engineers, the company aims to streamline the process of verifying AI-generated code by simulating user flows and identifying edge cases. This approach allows developers to quickly understand the impact of code changes, potentially accelerating the deployment process. With plans to expand into backend testing and grow its team, Meticulous is positioning itself as a key player in the AI code verification space.
Sifted
© TechCrunch AIInvestment · $200M
Market & Regulationbusiness
OpenAI's Miles Wang plans $2B AI drug startup
Miles Wang, an OpenAI researcher, is reportedly leaving to start a new AI-driven drug discovery company, potentially valued at $2 billion. This move highlights the growing trend of applying AI to accelerate breakthroughs in life sciences, with Wang's startup aiming to repurpose existing drugs for new uses. While the funding details are still in flux, the interest from investors like Lightspeed shows the potential impact of AI in the pharmaceutical industry. If successful, Wang's venture could significantly reduce the time and cost associated with bringing new treatments to market.
TechCrunch AI